Survey of medication therapy management programs under Medicare Part D

Journal of the American Pharmacists Association

Volumn 46, Issue 6, 2006, Pages 683-691

  Touchette, Daniel R ^a,b   Burns, Anne L ^c   Bough, Marcie A ^c   Blackburn, Juan C ^a,b  

^a Nashville Clinical Education Center and Statewide   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c AMERICAN PHARMACISTS ASSOCIATION   (United States)

Author keywords

Geriatrics; Health policy; Medicare Part D; Medication therapy management

Indexed keywords

CONTROLLED STUDY; E-MAIL; HEALTH CARE DELIVERY; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; INTERVIEW; MANAGER; MEDICAID; MEDICARE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; REVIEW; TELEPHONE; UNITED STATES;

EID: 33845940837     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544-3191.46.6.683.Touchette     Document Type: Article

References (62)

1. Public Law 108-173. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003. HR1. December 8, 2003. Accessed at www.cms.hhs.gov/EmplUnionPlanSponsorInfo/downloads/hr1.pdf, July 12, 2006.
2. Department of Health and Human Services. Centers for Medicare & Medicaid Services. 42 CFR Parts 400,403,411,417, and 423 [CMS-4068-F] Final Rule, Medicare program; Medicare prescription drug benefit. 42 CFR Parts 400,403,411,417, and 423 [CMS-4068-F] Final Rule, Medicare program; Medicare prescription drug benefit January 28, 2005. Accessed at www.cms.hhs.gov/ quarterlyproviderupdates/downloads/ CMS4068F.PDF, July 12, 2006.
3. Buffington DE. Pharmacist current procedural terminology codes and medication therapy management. Am J Health Syst Pharm. 2006;63: 1008-10.
4. Hunt JS, Siemienczuk J, Toucnette D, Payne N. Impact of educational mailing on the blood pressure of primary care patients with mild hypertension. J Gen Intern Med. 2004;19:925-30.
5. Williams ME, Pulliam CC, Hunter R, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52:93-8.
6. Allard J, Hebert R, Rioux M, et al. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ. 2001;164(9):1291-6.
7. Meyer TJ, Van Kooten D, Marsh S, Prochazka AV. Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med. 1991;6:133-6.
8. Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323:1340-3.
9. Stebbins MR, Kaufman D, Lipton HL. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacists- directed services. J Manag Care Pharm. 2005;11:333-41.
10. Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc. 2004;44:337-49.
11. Malone DC, Carter BL, Billups SJ, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20:1149-58.
12. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428-37.
13. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model. Arch Intern Med. 1984;144:1159-62.
14. Monson R, Bond CA, Schuna A. Role of the clinical pharmacist in improving drug therapy. Clinical pharmacists in outpatient therapy. Arch Intern Med. 1981;141:1441-4.
15. Department of Health and Human Services. Centers for Medicare & Medicaid Services. PDP Plan Enrollment by State (v.04.27.06). Center for Medicare & Medicaid Services. Accessed at www.cms.hhs.gov/ PrescriptionDrugCovGenln/02_EnrollmentData.asp, July 19, 2006.
16. Department of Health and Human Services. Centers for Medicare & Medicaid Services. MA-PD Plan Enrollment by County (v04.27.06). Accessed at www.cms.hhs.gov/PrescriptionDrugCovGenln/02_ EnrollmentData.asp, July 19, 2006.
17. Board on Health Care Services, Division of Health Care Services, Institute of Medicine. Priority areas for national action: transforming health care quality. Washington D.C.: National Academy Press; 2002.
18. Buajordet I, Ebbesen J, Erikssen J, et al. Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001;250:327-41.
19. Colt HG, Shapiro AP. Drug-induced illness as a cause for admission to a community hospital. J Am Geriatr Soc. 1989;37:323-6.
20. Hafner JW Jr., Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med. 2002;39:258-67.
21. Mackinnon NJ, Helper CD. Indicators of preventable drug-related morbidity in older adults 2. Use within a managed care organization. J Manag Care Pharm. 2003;9:134-41.
22. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868-79.
23. Meredith S, Feldman PH, Frey D, et al. Possible medication errors in home healthcare patients. J Am Geriatr Soc. 2001;49:719-24.
24. Krueger KP, Felkey BG, Berger BA. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. J Am Pharm Assoc. 2003;43:668-78.
25. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303-12.
26. Piette JD, Heisler M, Krein S, Kerr EA. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165:1749-55.
27. Carter BL, Malone DC, Billups SJ, et al. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm. 2001;58:1330-7.
28. Hanlon JT, Landsman PB, Cowan K, et al. Physician agreement with pharmacist-suggested drug therapy changes for elderly outpatients. Am J Health Syst Pharm. 1996;53:2735-7.
29. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother. 2001;35:835-40.
30. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30:205-11.
31. Malone DC, Carter BL, Billups SJ, et al. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Med Care. 2001;39:113-22.
32. Smith SR, Catellier DJ, Conlisk EA, Upchurch GA. Effect on health outcomes of a community-based medication therapy management program for seniors with limited incomes. Am J Health Syst Pharm. 2006;63:372-9.
33. Adler DA, Bungay KM, Wilson IB, et al. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry. 2004;26:199-209.
34. Borenstein JE, Graber G, Saltiel E, et al. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy. 2003;23:209-16.
35. Choe HM, Mitrovich S, Dubay D, et al. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005;11:253-60.
36. Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary • care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med. 2005;118:276-84.
37. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149-55.
38. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9(4 Pt 1):285-92.
39. Bouvy ML, Heerdink ER, Urquhart J, et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9(5):404-11.
40. Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101:270-6.
41. Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003;23:113-32.
42. Norris SL, Lau J, Smith SJ, et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25:1159-71.
43. Haynes RB, Yao X, Degani A, et al. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005(4):CD000011.
44. Carter BL, Helling DK. Ambulatory care pharmacy services: has the agenda changed? Ann Pharmacother. 2000;34:772-87.
45. Lipton HL, Byrns PJ, Soumerai SB, Chrischilles EA. Pharmacists as agents of change for rational drug therapy. Int J Technol Assess Health Care. 1995;11:485-508.
46. Tully MP, Seston EM. Impact of pharmacists providing a prescription review and monitoring service in ambulatory care or community practice. Ann Pharmacother. 2000;34:1320-31.
47. Fahey T, Schroeder K, Ebrahim S. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2006(2):CD005182.
48. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004(2):CD004804.
49. Schedlbauer A, Schroeder K, Peters TJ, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev. 2004(4):CD004371.
50. Forster AJ, Clark HD, Menard A, et al. Effect of a nurse team coordinator on outcomes for hospitalized medicine patients. Am J Med. 2005;118:1148-53.
51. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565-71.
52. Smith L, McGowan L, Moss-Barclay C, et al. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. Br J Clin Pharmacol. 1997;44:163-5.
53. Al-Rashed SA, Wright DJ, Roebuck N, et al. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002;54:657-64.
54. Sorensen L, Stokes JA, Purdie DM, et al. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58:648-64.
55. Piette JD, Weinberger M, Kraemer FB, McPhee SJ. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care. 2001;24:202-8.
56. Zillich AJ, Carter BL, Ernst ME, Kelly MW. Effect of a telephone medication renewal service on blood pressure control. J Am Pharm Assoc. 2003;43:561-5.
57. Wilt TJ, Paul J, Murdoch M, et al. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet. Eff Clin Pract. 2001;4:112-20.
58. Meischke H, Eisenberg MS, Schaeffer SM, et al. Impact of direct mail intervention on knowledge, attitudes, and behavioral intentions regarding use of emergency medical services for symptoms of acute myocardial infarction. Eval Health Prof. 1994;17:402-17.
59. Anonymous. Summary of the executive sessions on medication therapy management programs: Bethesda, Maryland, June 14 and August 18, 2004. Am J Health Syst Pharm. 2005;62:585-92.
60. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc. 2005;45:566-72.
61. Renders CM, Valk GD, Griffin SJ, et al. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24:1821-33.
62. Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the US. Ann Pharmacother. 2006;40:1400-6.